420 Lexington Avenue
Suite 2035
New York, NY 10170
United States
https://www.curaleaf.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 5,650
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Boris Alexis Jordan | Executive Chairman | 1.19M | N/A | 1966 |
Mr. Matthew S. Darin | Chief Executive Officer | 1.18M | N/A | N/A |
Mr. Edward Kremer | Chief Financial Officer | 764.02k | N/A | 1972 |
Mr. Peter Laurence Clateman J.D. | Chief Legal Officer | 644.76k | N/A | 1968 |
Mr. Camilo Russi Lyon | Chief Investment Officer | N/A | N/A | N/A |
Mr. Jakob Feinstein | Manager of Investor Relations | N/A | N/A | N/A |
Mr. James S. Shorris | Chief Compliance Officer | N/A | N/A | 1961 |
Ms. Tracy Brady | Senior Vice President of Corporate Communications | N/A | N/A | N/A |
Ms. Kate Lynch | Executive Vice President of Marketing | N/A | N/A | N/A |
Ms. Tyneeha Rivers | Chief People Officer | N/A | N/A | N/A |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
Curaleaf Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.